Both doxorubicin and actinomycin-D are components of Wilms tumor chemotherapy; a high expression of MDR3 and MRP1 has been shown to confer resistance in children with Wilms tumor and a significant correlation has been demonstrated with clinicopathological parameters [58]. Here, ABCC1 is linked to Nephroblastoma.